Senate Rejects House-Led Ethics Bill, Labeling Proposed Insider Trading Reform a "Ruse"
Main Facts: The Collapse of the Proposed Legislation In a significant legislative standoff, the United States Senate has officially rejected a House-approved bill aimed at addressing congressional stock trading practices.…
Transparency in the Balance: The Case for Including Negative Trial Data in FDA Drug Labeling
The regulatory landscape for pharmaceuticals is built on a foundation of trust. Physicians, pharmacists, and patients rely on the Food and Drug Administration (FDA) to act as a rigorous filter,…











